Lilly Asia Ventures Fund III L.P. 13D and 13G filings for NextCure, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 3:02 pm Sale |
2022-12-31 | 13G | NextCure, Inc. NXTC |
Lilly Asia Ventures Fund III L.P. | 0 0.000% |
-1,704,391 (Position Closed) |
Filing |
| 2022-02-09 12:20 pm Sale |
2021-12-31 | 13G | NextCure, Inc. NXTC |
Lilly Asia Ventures Fund III L.P. | 1,704,391 6.200% |
-384,468 (-18.41%) |
Filing |